Table 2 Patient surgical and pathological backgrounds
Surgical procedure | FAS (n = 38) | PPS (n = 36) |
Operation time (hours) | 3.36 ± 1.23 | 3.37 ± 1.25 |
Blood loss (g) | 138.6 ± 126.2 | 127.7 ± 114.6 |
Surgical procedure | ||
Lobectomy | 26 (68.4 %) | 24 (66.7 %) |
Segmentectomy | 7 (18.4 %) | 7 (19.4 %) |
Wedge resection | 7 (18.4 %) | 7 (19.4 %) |
Combined resection | 3 (7.9 %) | 3 (8.3 %) |
Residual tumor | ||
R0 | 36 (94.7 %) | 34 (94.4 %) |
R1 | 1 (2.6 %) | 1 (2.8 %) |
R2 | 1 (2.6 %) | 1 (2.8 %) |
Cancer pathology | FAS (n = 38) | PPS (n = 36) |
Pathological type | ||
Squamous cell carcinoma | 18 (47.4 %) | 18 (50.0 %) |
Adenocarcinoma | 16 (42.1 %) | 14 (38.9 %) |
Large cell carcinoma | 0 (0.0 %) | 0 (0.0 %) |
Adenosquamous carcinoma | 1 (2.6 %) | 1 (2.8 %) |
Other | 3 (7.9 %) | 3 (8.3 %) |
Pathological stage | ||
IA | 10 (26.3 %) | 10 (27.8 %) |
IB | 12 (31.6 %) | 10 (27.8 %) |
IIA | 8 (21.1 %) | 8 (22.2 %) |
IIB | 4 (10.5 %) | 4 (11.1 %) |
IIIA | 2 (5.3 %) | 2 (5. %) |
IIIB | 0 (0.0 %) | 0 (0.0 %) |
IV | 1 (2.6 %) | 1 (2.8 %) |
(non-cancer) | 1 (2.6 %) | 1 (2.8 %) |